GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (ISX:KAEF) » Definitions » Total Equity

PT Kimia Farma Tbk (ISX:KAEF) Total Equity : Rp5,708,946 Mil (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is PT Kimia Farma Tbk Total Equity?

PT Kimia Farma Tbk's total equity for the quarter that ended in Sep. 2024 was Rp5,708,946 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

PT Kimia Farma Tbk Total Equity Historical Data

The historical data trend for PT Kimia Farma Tbk's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk Total Equity Chart

PT Kimia Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,412,926.83 7,105,672.05 5,889,424.17 8,002,755.71 6,392,705.33

PT Kimia Farma Tbk Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,442,036.47 6,392,705.33 6,104,628.48 5,932,957.05 5,708,946.05

PT Kimia Farma Tbk Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

PT Kimia Farma Tbk's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=17585297.583-11192592.254
=6,392,705

PT Kimia Farma Tbk's Total Equity for the quarter that ended in Sep. 2024 is calculated as

Total Equity=Total Assets(Q: Sep. 2024 )-Total Liabilities(Q: Sep. 2024 )
=16802347.355-11093401.309
=5,708,946

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Kimia Farma Tbk Total Equity Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Kimia Farma Tbk Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (ISX:KAEF) » Definitions » Total Equity
Comparable Companies
ISX:SOHO ISX:EPMT ISX:IRRA ISX:ZBRA ISX:SDPC MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459 TSE:2784 PDCO SHSE:600739 TSE:9987 SHSE:600056
Traded in Other Exchanges
N/A
Address
Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110
Website
https://www.kimiafarma.co.id
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.

PT Kimia Farma Tbk Headlines

No Headlines